Project Grant R01DE035850
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $121,667 on April 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to synthesize, characterize, and validate granular hydrogel platforms for the theranostic management of periodontitis. The project develops three classes of thiolated chitosan microgel-based hydrogels: diagnostic formulations functionalized with MMP-2 and MMP-9 susceptible fluorescent peptides for...
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $634,041 on May 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate protein interaction networks and posttranscriptional gene regulation in Streptococcus mutans, the dominant species associated with dental caries risk. The research employs a multidisciplinary approach integrating genetics, advanced mass spectrometry, next-generation sequencing,...
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $429,000 on July 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate how extracellular membrane vesicles from the oral commensal bacterium Streptococcus sanguinis modulate interferon signaling in epithelial cells. The research employs biochemical, proteomic, and transcriptomic approaches to define the molecular mechanism by which a predicted...
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $524,669 on June 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate how Streptococcus sanguinis extracellular vesicles regulate gingival homeostasis and periodontal immune defense. The research explores the dual role of S. sanguinis, an early oral biofilm colonizer that both promotes oral health and exhibits pro-inflammatory traits. The project...
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health under the Department of Health and Human Services, awarded The University of Chicago $328,000 on August 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate a microsimulation model of oral health lifetime outcomes and resource use in older adults. The project, titled "Development and Validation of the U.S. Oral Health Microsimulation...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Oregon State University a $422,665 Project Grant on June 17, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop an integrated dental plaque bioanalytical platform for point-of-care diagnostics of oral diseases. The research addresses the significant financial burden of dental caries by creating a quantitative electrochemical biosensing platform capable...
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $900,000 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the role of perivascular stromal cells in temporomandibular joint osteoarthritis progression. The research examines how perivascular stem and stromal cells within the temporomandibular joint synovium regulate joint homeostasis and contribute to osteoarthritis severity, with...
- Federal Grant Award Summary Oregon Health & Science University received $597,807 in Project Grant funding from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) to establish a novel 13C-labeled oral bacterial metabolite reference library for studying dental caries. The award, effective August 19, 2025, with completion targeted for July 31, 2027, supports the development of a comprehensive metabolite...
- The National Institute of Dental and Craniofacial Research awarded the University of Massachusetts Lowell $100,676 on September 30, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop a three-dimensional in vitro human periodontal sulcus tissue model capable of reproducing healthy and disease states of gingivitis and periodontitis. The recipient will engineer a sustained tissue culture system that mimics key anatomical features of the gingival sulcus—including...
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health within the Department of Health and Human Services, awarded $435,875 to Indiana University Indianapolis on July 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate oxylipin-mediated biofilm colonization in peri-implant disease. The research explores the role of oxylipins in regulating bacterial biofilm formation around dental implants. The study aims...
The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $557,951 on August 26, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate an experimental polymicrobial abscess model system for investigating the role of microbial synergy in oral inflammatory dysbiosis. The research platform uses patient-matched human dental plaque and odontogenic abscess specimens introduced into mice to recapitulate the complex interplay between microbiome ecology and dysregulated host inflammatory control. The model demonstrates that abscess-derived microcosms induce higher-virulence abscesses than patient-matched dental plaque microcosms, and that mouse passaging experiments reveal how inflammatory selective pressure remodels both dental plaque and abscess communities into reduced-diversity inflammophilic communities that trigger persistent unresolving abscesses. The work includes immunoprofiling comparisons to identify distinct neutrophil phenotypes and cytokine responses unique to unresolving abscesses, addressing a fundamental knowledge gap in understanding the host mechanisms sustaining chronic oral dysbiotic diseases. Performance occurs in Portland, Oregon 97239 with a period of performance extending through July 31, 2031. This is a project grant, the standard assistance type for NIH investigator-initiated research under the Oral Diseases and Disorders Research program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $558.0k | 8/27/26 |